NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Bo G Eriksson
University of Gothenburg - Göteborg / Sweden
Others
AD Scientific Index ID: 1219791
Göteborgs universitet
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Bo G Eriksson's MOST POPULAR ARTICLES
1-)
Suggested Minimal Effective Dose of Risperidone Based on PET-Measured D2 and 5-HT2A Receptor Occupancy in Schizophrenic PatientsS Nyberg, B Eriksson, G Oxenstierna, C Halldin, L FardeAmerican Journal of Psychiatry 156 (6), 869-875, 19993301999
2-)
5-HT2 and D2 dopamine receptor occupancy in the living human brain: A PET study with risperidoneS Nyberg, L Farde, L Eriksson, C Halldin, B ErikssonPsychopharmacology 110, 265-272, 19932861993
3-)
Efficacy and safety of risperidone in the long-term treatment of patients with schizophreniaE Lindström, B Eriksson, A Hellgren, L von Knorring, G EberhardClinical Therapeutics 17 (3), 402-412, 19951501995
4-)
Quality of life among children in the Nordic countriesB Lindström, B ErikssonQuality of Life Research 2, 23-32, 19931351993
5-)
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophreniaO Gefvert, B Eriksson, P Persson, L Helldin, A Björner, E Mannaert, ...International Journal of Neuropsychopharmacology 8 (1), 27-36, 20051332005
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept